RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • 30 Years Later, FDA Looks Back on Passage of Orphan Drug Act

    • 04 January 2013
    • By
    It's been a momentous few months for the US Food and Drug Administration (FDA)-a time to look back and reminisce about where the agency has come from and what it has endured along the way. In October 2012, the agency celebrated the milestone of 50 years since the passage of the Kefauver-Harris Amendments to the Federal Food, Drug and Cosmetic Act , which endowed the agency with the authority to assess the efficacy of drugs and the processes by which they were manufac...
  • Genome Sequencing Costs Set To Plunge Below $1,000 For The First Time

    • 10 January 2012
    • By
    A Connecticut company, Life Technologies Corp, is announcing that they have manufactured a machine that has  broken the $1,000 genome sequencing barrier that has long been seen as a milestone in providing affordable sequencing technologies to the public. The machine itself is set to cost between $99,000 and $149,000-well below the $750,000 that some current genome sequencing models cost. The machine reportedly uses materials that can sequence the an entire human ge...